Gapping down
In reaction to disappointing earnings/guidance: KNDI -12%, PLUG -8.3%, NVAX -6.8%, PCLN -5.9%, EVEP -4.8%, AOI -3%, ANTH -3%, BITA -2.8%, MNKD -2.4%, FXEN -0.9%
M&A news: WY -3.7% (Weyerhaeuser and Plum Creek (PCL) to merge; all-stock transaction followed by $2.5 bln post-closing share repurchase; WY to review strategic alternatives for its Cellulose Fibers business)
Select large pharma names showing weakness: SNY -2.1%, AZN -1.7%, SHPG -1.6%, NVS -1%, GSK -0.5%
Other news: XOMA -8.9% (cont weakness), NBG -5.3% (still checking), AGIO -5.1% (reports data from dose-escalation Phase 1 study of AG-120), ITUB -2.5% (still checking), CALA -2.4% (reports new Phase 1 solid tumor dose expansion data of CB-839), BHP -1.3% (updates on the incident at its Samarco mine, places FY16 production guidance under review)
Analyst comments: GLUU -4.3% (downgraded to Hold at The Benchmark Company), CENX -2.2% (downgraded to Neutral from Buy at Nomura), SNY -2.1% (downgraded to Mkt Perform from Outperform at Bernstein), OVAS -1.9% (downgraded to Mkt Perform from Outperform at Leerink Partners), ADSK -1.5% (downgraded to Neutral from Buy at UBS ), SSYS -1.3% (downgraded to Hold from Buy at Deutsche Bank), CTIC -0.8% (downgraded to Hold at WallachBeth), AA -0.7% (downgraded to Neutral from Buy at Nomura), QCOM -0.6% (downgraded to Neutral from Buy at Nomura)
.
In reaction to disappointing earnings/guidance: KNDI -12%, PLUG -8.3%, NVAX -6.8%, PCLN -5.9%, EVEP -4.8%, AOI -3%, ANTH -3%, BITA -2.8%, MNKD -2.4%, FXEN -0.9%
M&A news: WY -3.7% (Weyerhaeuser and Plum Creek (PCL) to merge; all-stock transaction followed by $2.5 bln post-closing share repurchase; WY to review strategic alternatives for its Cellulose Fibers business)
Select large pharma names showing weakness: SNY -2.1%, AZN -1.7%, SHPG -1.6%, NVS -1%, GSK -0.5%
Other news: XOMA -8.9% (cont weakness), NBG -5.3% (still checking), AGIO -5.1% (reports data from dose-escalation Phase 1 study of AG-120), ITUB -2.5% (still checking), CALA -2.4% (reports new Phase 1 solid tumor dose expansion data of CB-839), BHP -1.3% (updates on the incident at its Samarco mine, places FY16 production guidance under review)
Analyst comments: GLUU -4.3% (downgraded to Hold at The Benchmark Company), CENX -2.2% (downgraded to Neutral from Buy at Nomura), SNY -2.1% (downgraded to Mkt Perform from Outperform at Bernstein), OVAS -1.9% (downgraded to Mkt Perform from Outperform at Leerink Partners), ADSK -1.5% (downgraded to Neutral from Buy at UBS ), SSYS -1.3% (downgraded to Hold from Buy at Deutsche Bank), CTIC -0.8% (downgraded to Hold at WallachBeth), AA -0.7% (downgraded to Neutral from Buy at Nomura), QCOM -0.6% (downgraded to Neutral from Buy at Nomura)
.